Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus

Diabetic Medicine

Volumn 29, Issue 6, 2012, Pages 721-725

  Resl, M ^a   Clodi, M ^a   Neuhold, S ^a   Kromoser, H ^a   Riedl, M ^a   Vila, G ^a   Prager, R ^b   Pacher, R ^a   Strunk, G ^c   Luger, A ^a   Hulsmann M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Hietzing Hospital Vienna   (Austria)

^c VIENNA UNIVERSITY OF ECONOMICS AND BUSINESS   (Austria)

Author keywords

Diabetes; Uric acid

Indexed keywords

ALBUMIN; ALLOPURINOL; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ADULT; AGE; ALBUMINURIA; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTOR VARIABLE; PROSPECTIVE STUDY; SMOKING; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

ALBUMINURIA; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RISK FACTORS; URIC ACID;

EID: 84861171948     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03515.x     Document Type: Article

References (25)

1. Schramm TK, Gislason GH, Kober L, Rasmussen S, Rasmussen JN, Abildstrom SZ et al. Diabetes patients requiring glucose-lowering therapy and non-diabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 2008; 117: 1945-1954.
2. Niskanen L, Laaksonen DE, Lindstrom J, Eriksson JG, Keinanen-Kiukaanniemi S, Ilanne-Parikka P et al. Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance: the Finnish Diabetes Prevention Study. Diabetes Care 2006; 29: 709-711.
3. Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 2000; 10: 136-143.
4. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-1821.
5. Hoieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004; 65: 1041-1049.
6. Iribarren C, Folsom AR, Eckfeldt JH, McGovern PG, Nieto FJ. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol 1996; 6: 331-340.
7. Fukui M, Tanaka M, Shiraishi E, Harusato I, Hosoda H, Asano M et al. Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type2 diabetes mellitus. Metabolism 2008; 57: 625-629.
8. Muscelli E, Natali A, Bianchi S, Bigazzi R, Galvan AQ, Sironi AM et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 1996; 9: 746-752.
9. Ter Maaten JC, Voorburg A, Heine RJ, Ter Wee PM, Donker AJ, Gans RO. Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci (Lond) 1997; 92: 51-58.
10. Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005; 118: 816-826.
11. Ho WJ, Tsai WP, Yu KH, Tsay PK, Wang CL, Hsu TS et al. Association between endothelial dysfunction and hyperuricaemia. Rheumatology (Oxford) 2010; 49: 1929-1934.
12. George J, Struthers A. The role of urate and xanthine oxidase in vascular oxidative stress: future directions. Ther Clin Risk Manag 2009; 5: 799-803.
13. Tarnow L, Gall MA, Hansen BV, Hovind P, Parving HH. Plasma N-terminal pro-B-type natriuretic peptide and mortality in type2 diabetes. Diabetologia 2006; 49: 2256-2262.
14. Huelsmann M, Neuhold S, Strunk G, Moertl D, Berger R, Prager R et al. NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus. Eur Heart J 2008; 29: 2259-2264.
15. Maier C, Clodi M, Neuhold S, Resl M, Elhenicky M, Prager R et al. Endothelial markers may link kidney function to cardiovascular events in type2 diabetes. Diabetes Care 2009; 32: 1890-1895.
16. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and non-diabetic individuals. J Am Med Assoc 2001; 286: 421-426.
17. Zoppini G, Targher G, Negri C, Stoico V, Perrone F, Muggeo M et al. Elevated serum uric acid concentrations independently predict cardiovascular mortality in type2 diabetic patients. Diabetes Care 2009; 32: 1716-1720.
18. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. J Am Med Assoc 2008; 300: 924-932.
19. Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M et al. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 2004; 94: 932-935.
20. Noman A, Ang DS, Ogston S, Lang CC, Struthers AD. Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial. Lancet 2010; 375: 2161-2167.
21. Forman JP, Choi H, Curhan GC. Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med 2009; 169: 155-162.
22. Johnson RJ, Feig DI, Herrera-Acosta J, Kang DH. Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension 2005; 45: 18-20.
23. Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008; 168: 1104-1110.
24. Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD et al. Uric acid and inflammatory markers. Eur Heart J 2006; 27: 1174-1181.
25. Waring WS, McKnight JA, Webb DJ, Maxwell SR. Uric acid restores endothelial function in patients with type1 diabetes and regular smokers. Diabetes 2006; 55: 3127-3132.